You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD8683 After Single Ascending Doses Administered Via Turbuhaler in Healthy Subjects
- Disease
- pharmacokinetics
- Drug Name
- AZD8683
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D1883C00006
- Study Id
- D1883C00006
- ClinicalTrials.gov ID
- NCT01419600
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
